chr2-237336281-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_004369.4(COL6A3):c.8819C>T(p.Thr2940Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000199 in 1,614,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T2940T) has been classified as Benign.
Frequency
Consequence
NM_004369.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A3 | NM_004369.4 | c.8819C>T | p.Thr2940Met | missense_variant | Exon 40 of 44 | ENST00000295550.9 | NP_004360.2 | |
COL6A3 | NM_057167.4 | c.8201C>T | p.Thr2734Met | missense_variant | Exon 39 of 43 | NP_476508.2 | ||
COL6A3 | NM_057166.5 | c.6998C>T | p.Thr2333Met | missense_variant | Exon 37 of 41 | NP_476507.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152228Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000207 AC: 52AN: 250706Hom.: 0 AF XY: 0.000236 AC XY: 32AN XY: 135760
GnomAD4 exome AF: 0.000202 AC: 295AN: 1461686Hom.: 0 Cov.: 31 AF XY: 0.000179 AC XY: 130AN XY: 727140
GnomAD4 genome AF: 0.000171 AC: 26AN: 152346Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74496
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
- -
Inborn genetic diseases Uncertain:1
The c.8819C>T (p.T2940M) alteration is located in exon 40 (coding exon 39) of the COL6A3 gene. This alteration results from a C to T substitution at nucleotide position 8819, causing the threonine (T) at amino acid position 2940 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Bethlem myopathy 1A Benign:1
- -
Collagen 6-related myopathy Benign:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at